http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Fruit Quality Attributes of Blackberry (Rubus sanctus) Mutants Obtained by ^(60)Co Gamma Irradiation
Pervin Basaran,Kahraman Kepenek 한국생물공학회 2011 Biotechnology and Bioprocess Engineering Vol.16 No.3
Blackberry mutants were induced by the irradiation of blackberry shoots with 5 kilo radians of cobalt (^(60)Co) gamma irradiation. Seven mutant plants demonstrating improved plant growth properties were selected for evaluation of the fruit quality characteristics, such as size,shape, color, firmness, soluble solids content, juice acidity,nutritive value (e.g. ascorbic acid) and overall fruit flavor. The organoleptic properties, including texture, firmness,flavor, sweetness, acidity, color, and overall fruit flavor,were evaluated by a consumer panel. The results indicated that irradiation induced changes in some of the quality parameters of blackberry fruits, as well as increased the fruit shelf-life.
An Assessment of Emerging Molecular Farming Activities Based on Patent Analysis (2002~2006)
Pervin Basaran,Emilio Rodriguez-Cerezo 한국생물공학회 2008 Biotechnology and Bioprocess Engineering Vol.13 No.3
The products of Plant Molecular Farming are recombinant proteins or their metabolic products. In this study, patent data was employed to assess industrial trend in the research and innovation process of Plant Molecular Farming within national and international context. The US Patent and Trade Organization (USPTO), the European Patent Office (EPO) issued a total of 585 patents covering Plant Molecular Farming from 2002 through 2006. By nationality, US inventors predominated as recipients of PMF patents, followed by Germany, Denmark, and Japan. The PMF patents were catagorized in five major areas of research namely pharmaceutical and nutraceuticals with 170 patents (31%) and plant expression tools and methods for alternative production systems with 169 patents (29%) were the dominating patent applications, followed by 102 patent claims associated with antibodies (17%), 71 patents of industrial molecules (12%), 48 patents of vaccines (8%), and finally 18 patents related to post-translational protein glycosylation (3%). The greatest proportion of patentees was of US origin (52%), and PMF associated patenting activities at the USPTO and EPO were dominated with 67% by private organizations.